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Abstract. – Castleman’s disease (giant lymph
node hyperplasia, angiofollicular hyperplasia,
lymphoid hamartoma, benign giant lymphoma), is
a quite rare and complex disease of lymphoid tis-
sue that causes progressive lymph node enlarge-
ment, typically presenting as a solitary mediasti-
nal mass. It was first described by Castleman et al
in 1956. The head and neck regions are the sec-
ond, less common site for this lesion. The preop-
erative diagnosis is very often extremely difficult
and the routine investigations are often inconclu-
sive. A multicentric extension of this disease
shows poorer prognosis compared to the unifocal
Histologically, three types do exist: the hya-
line-vascular type, the plasma cell type and the
mixed type. The etiology and pathogenesis is
still unclear. In the literature, to our knowledge,
only 112 cases have been reported involving
head and neck, and only 22, including our own,
interesting the parotid gland. In this report we
describe a rare singular of Castleman’s disease
presenting as a tumor of the inferior pole of the
parotid gland extending in the submandibular
region, in a 35-year-old woman. The patient un-
dergone a surgical treatment and, therefore, the
mass was successfully totally removed.
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Introduction
Castleman’s disease is an uncommon benign
lymphoproliferative disorder that is characterized
by hypervascular lymphoid hyperplasia1 .The
head and neck compartments represent the sec-
ond site of location, being the mediastinum the
most common region involved. Its etiopathology
is still unknown, but some hypothesis have been
suggested in recent years, it can be the result of a
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chronic antigenic stimulation, excessive produc-
tion of interleukin-6 by the involved lymph node
has been considered also, and there are several
clinical observations that it may be also associat-
ed to chronic inflammatory process, viral infec-
tions as Epstein-Barr, Kaposi’s sarcoma, Herpes
Virus, immunological disturbance and neoplastic
formation. The disease can have unicentric or
multicentric locations and in most of cases is
asymptomatic, or compressive symptoms can be
described due to the size. The multicentric cases
present with poly-lymphadenopathy and multi-
organ involvement, therefore, is associated to
systemic symptoms. Hystologically three differ-
ent types have been described: the hyaline vascu-
lar type, the plasma cell type, and the mixed
type. A plasmablastic variant, recently observed,
is associated to Human herpes Virus 8 (HHV8)
and Human Immunodeficiency Virus (HIV) and
is extremely aggressive2,3. The location of this
disease within the parotid gland is very rare and
very few cases have been reported to date. The
diagnosis can be possible only by histological
examination and the radiological exams are not
exhaustive. The optimal treatment of the unicen-
tric variant can be surgery alone, the multicentric
variants, because of their heterogeneity and com-
plex spectrum of disease, can be sometimes ex-
tremely difficult to treat.
Case Report
A 35-year-old woman with a swelling in the
right submandibular lodge, was observed in our
Department on February 2006. The patient had
undergone a right superficial parotidectomy, with
preservation of the facial nerve, in another Cen-
ter on July 1987 because of a neoformation of
the parotid gland diagnosed as benign limphoep-
ithelial tumor at histological sections. She had no
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Figure 1. Lateral view of the patient: the previous Redon
scar is appreciable.
Figure 2. Preoperative CT of patient: a, The red arrow in-
dicates the tumour mass; the black arrow indicates the sub-
mandibular gland. It is evident the space between the tu-
mour and the gland. b, The red arrow shows the posterior
and upper portion of the tumour mass in relationship with
the parotid gland tissue.
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systemic symptoms but only a not aesthetical
swelling in the right submandibular area and a
scar of the previous surgery, a classic Redon
parotid approach (Figure 1). Physical examina-
tion of the neck regions, showed that the mass
was located in close proximity of the right sub-
mandibular gland. Its dimensions were 4 × 3 cm,
and it was mobile and nonpulsatile, with a rub-
bery firm consistency and well defined borders.
Computed Tomography of the neck confirmed
the presence of a well-circumscribed ovoid mass,
approximately 4 cm in maximum diameter, lo-
cated in the inferior portion of the right parotid
gland, and developing antero-inferiorly, in con-
tact with the submandibular gland, mimicking a
possible pleomorphic adenoma (Figures 2a, b).
Fine-needle aspiration biopsy revealed a mixed
population of lymphoid cells, a specific reactive
hyperplasia, and no evidence of malignant cells.
The patient underwent total excision of the tu-
mor. In order to directly approach the lesion, the
skin incision was performed in the submandibu-
lar region. The mass had developed in between
the inferior pole of the parotid and submandibu-
lar glands, tightly adherent to, and arising from
the parenchyma of the parotid gland, without an
evident cleavage plan, and in contact with the
posterior pole of the submandibular gland, being
clearly separated by a cleavage plan (Figures 3a,
3b). The histopathological examination was in
favour of a hyaline vascular type of giant lymph
node hyperplasia (Figures 4a, 4b). At a recent
follow-up the patient is still disease free.
Discussion
Castleman’s disease was first described by
Castleman et al in 1956 in 13 cases involving a
type of mediastinal mass, describing it as a lo-
calised mediastinal lymph node hyperplasia re-
sembling thymoma1. Until 2001 only 60 cases in-
volving head and neck had been described4. Af-
ter extensive review of the literature, to our
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Figure 3. a, Skin marker painting the inferior border of
the mandible and the tumour mass. b, Specimen: the re-
moved mass measures 6 × 4 cm.
Figure 4. a, 20 × magnification: Castleman’s disease as-
sociated with marked vascular proliferation in the interfol-
licular tissue. b, 40 ×: Higher magnification shows follicles
often radially penetrated by a blood vessel (lollipop follicle)
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The hyaline vascular type is the most common
type of this disease (80-90%), and is charac-
terised by large fibrous masses and proliferation
of small hyalinized lymphoid follicles surround-
ed by a dense cellular matrix of small lymphoid
cells with marked interfollicular vascular prolif-
eration35,36,46; small vessels in the perivascular
area are mixed with intersperses areas of plasma
cells; the vessels show hyalinisation of their
walls and are surrounded by sheets of lympho-
cytes with an “onion skin” appearance.
Clinically this type presents as an asympto-
matic enlarging mass. The plasma cell type oc-
curs uncommonly and is histologically represent-
ed by sheets of mature plasma cells in the inter-
follicular tissue with small areas of hyaline17,20,36.
This type is very often associated to constitution-
al and systemic symptoms such as fatigue,
knowledge, 112 cases involving head and neck
have been described to date in the pertinent liter-
ature1,4-33 and only 22 cases, including our own,
involving the parotid gland4,21,25,31,32,34-44. It can
occur at any age but most of cases are adoles-
cents and young adults between 15 and 35 years
of age, with no sex predilection. The aetiology
and the pathogenesis of Castleman’s disease is
poorly understood and remains to be established.
It has been supposed that this disease can be the
result of a chronic antigenic stimulation, possibly
viral An excessive production of interleukin-6 by
the involved lymph node can be implicated in the
pathogenesis of this disease, because of its
hematopoietic and angiogenic effects. The dis-
ease usually arises as a solitary mass, commonly
found in the mediastinum (60%), neck (14%),
retroperitoneum (11%), or maxilla (4%)45,46.
Within the neck the Castleman’s disease usually
presents as an asymptomatic solitary mass locat-
ed deep to the sternocleidomastoid muscle. In
our case the lesion was located superficially,
mimicking a parotid gland tumor.
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nia, bone marrow plasmacytosis. The plasma cell
type is considered to be a serious risk for PO-
EMS syndrome (polyneuropathy, organomegaly,
endocrinopathy, M protein and skin changes) and
lymphoma. The multicentric variant is a systemic
disease presenting with disseminated lym-
phadenopathy, hepatosplenomegaly, nephritic
disease and constitutional symptoms34,48. It is of-
ten associated to malignancies including Ka-
posi’s sarcoma, Hodgkin’s lymphoma, non-
Hodgkin’s lymphoma and POEMS syndrome.
The prognosis is poor with a median range of
survival between 14 and 30 months. The Human
Herpes Virus-8 associated multicentric plasma
cell variant, also called plasmablastic variant, a
newly established subtype, is typical of immun-
odepressed individuals, especially HIV positive
patients, is extremely aggressive, and the progno-
sis is very poor and the survival time of patients
is some weeks49.
The high grade of difficulty in the diagnosis is
related to a paucity of signs and symptoms in the
unicentric variants, and to the absence of diag-
nostic specific markers and to the ability of
Castleman’s disease to mimic other neoplasms of
the head and neck, therefore the diagnosis is a re-
al challenge. Giant lymph node hyperplasia can
be confused with other neoplasms of the head
and neck, such as branchial cleft cyst, heman-
gioma, lymphangioma, dermoid cyst, teratoma,
thyroglossal duct cyst, thyroid pyramidal lobe,
adenopathy, lipoma, lymphoma, sarcoma,
metastatic nodes. Indeed Denenberg and Levine
described Castleman’s disease as “the lymphoma
impostor”11.
The laboratory tests can be helpful in the dif-
ferential diagnosis but are always inconclusive.
The computed tomography (CT) scans usually
show a well circumscribed homogeneous soft
tissue mass with variable contrast enhancement
depending on the injection rate and volume of
contrast media; the hyaline vascular type en-
hance more than the plasma cell type due to its
greater vascularity. The CT is not diagnostic be-
cause other pathologies, such as lymphoma, tu-
berculosis, metastatic thyroid carcinoma, Ka-
posi’s sarcoma, show the same features. Never-
theless, it has been recently suggested that the
presence of a non-enhanced stellar scar within
the center of the mass, due to dense fibrous tis-
sue, could be a diagnostic clue21. On Magnetic
Resonance (MR) Castleman’’s disease shows a
linear hypointense signal in a stellate or arboriz-
ing pattern, especially on T2-weighted se-
sweats, systemic haematological abnormalities
like anaemia, hypoalbuminaemia, hypergamma-
globulinaemia, leukocytosis, elevated sedimenta-
tion rate, because this type can show poly-
limphadenopathy and multi-organ involvement.
It may be associated to chronic inflammatory
process, viral infections as Epstein-Barr, Ka-
posi’s sarcoma, Herpes Virus, immunological
disturbance and neoplastic formation. It has been
hypothesized that the plasma cell type is the ear-
lier, more active stage of the process and the hya-
line vascular type represents the final phase25 .
The mixed type is represented by elements of
both the hyaline vascular and plasma cell types
and could be an intermediate variant. Recently
the plasma-blastic multicentric Castleman’s dis-
ease variant has been classified, because of its
aggressiveness and the constant association to
Human Herpes Virus-8 (HHV-8) and Human Im-
munodeficiency Virus (HIV)2,3,14,47. Clinically the
disease can be classified as unicentric, if a single
node or localized groups of nodes are involved,
and there are no general symptoms or symptoms
are due only to local compression, and multicen-
tric, with involvement of several lymph-node sta-
tions and organs32. All the cases reported in the
literature with parotid region involvement
showed increasing swelling of the gland and no
other general symptoms; only a case has been de-
scribed with bilateral parotid involvement42. In
our case it is interesting to note that the patient
was operated on nineteen years before, because
of a tumor of the parotid gland diagnosed as a
lymphoepithelial tumor, obviously misdiagnosed
and not correlated to Castleman’s disease. The
records of the patient describe the surgery as a
total removal of the tumor; perhaps the previous
surgery was not a real total removal, and we have
not studied the postoperative CT because the pa-
tient lost it, or at time of the first surgery another
lesion, located more inferiorly, was not identified
or, moreover, our case is a recurrence. The hya-
line vascular type, which is the most common
type, usually present unicentrically and affects
men and women equally, the median age is 40-
50 years. The levels I, IV and V in the neck are
more commonly involved, the parotid area and
nasopharynx are extremely rarely involved. The
plasma cell type is more commonly multicentric
than unicentric. The less frequent unicentric vari-
ant of plasma cell type is associated with sys-
temic symptoms and abnormal laboratory find-
ings. The common symptoms are fever, night
sweats, malaise, splenomegaly, anaemia, cytope-
quences, due to perivascular lamellar fibrosis or
sinus histiocytes and radial fibrosis; these pecu-
liar features have been considered an important
diagnostic clue of this pathology21.
Surgical excision is the treatment of choice for
this pathology in the head and neck with a 100%
control rate for the hyaline vascular type, and be-
cause of the hystopathologic examination, exci-
sion is both diagnostic and therapeutic with no
recurrences in the unicentric variants. The multi-
centric disease is much more complex to treat;
chemotherapy with cyclophosphamide and pred-
nisolone and also radiotherapy have been sug-
gested50, but considering the rarity of the disease
and the small number of cases described in the
literature further studies are needed.
Conclusions
Castleman’s disease is a heterogeneous disor-
der that can represent a continuous spectrum of
disease or several different diseases all together;
clinically it might be asymptomatic or could be
lethal, the final diagnosis can be made by
histopathological evaluation, therefore the treat-
ment has to be surgery, that appears to be cura-
tive in local lesions; in inoperable or systemic
variants the treatment is radiation therapy and
chemotherapy.
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